EHR

Elation Health Awarded for Leadership, Advancement of Primary Care and Digital Health

The primary care EHR leader has received recognition for elevating high-value healthcare standardsSAN FRANCISCO--(BUSINESS WIRE)--Elation Health, the clinical-first technology company…

8 months ago

MEDITECH Vice Chairman Howard Messing Honored With the CHIME Foundation Industry Leader Award

The healthcare IT pioneer and longtime MEDITECH CEO was recognized for his outstanding contributions to the industry and the CHIME…

8 months ago

St. Joseph’s/Candler Fast Tracks Implementation of MEDITECH Expanse Ambulatory Across 100+ Providers

Expanse Oncology the next step toward creating a single, patient-centered EHRCANTON, Mass.--(BUSINESS WIRE)--St. Joseph’s/Candler Health System (Savannah, GA) has taken…

8 months ago

Ambulatory Healthcare Professionals from Across the U.S. Gather in Orlando to Explore How Technology Can Maximize Patient Outcomes

During 140+ Sessions, UGM23 Attendees will Learn about AI-Driven Ambient Listening to Reduce Physician Burnout and other HealthTech InnovationsREMOTE-FIRST COMPANY/ORLANDO,…

8 months ago

AstraZeneca advances scientific leadership in hematology at ASH 2023

CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of…

8 months ago

Gain Therapeutics to Participate in AI Driven Drug Discovery Summit

BETHESDA, Md., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (Nasdaq: GANX), a clinical-stage biotechnology company leading the discovery…

8 months ago

BrightInsight Ranked 307th Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500

Multiple global digital launches, product and platform enhancements and new partnerships in 2023 contributed to 431% revenue growth for biopharma…

8 months ago

Valo Therapeutics Announces Regulatory Approval to Expand Phase I Immuno-oncology Trial into Sarcoma

Four cancer types now included in PeptiCRAd-1 with Pembrolizumab trial: sarcoma, melanoma, triple negative breast cancer and non-small cell lung…

8 months ago

Saviynt To Demonstrate How Enterprise Identity Cloud Supports Greater Efficiency, Security, and Patient Care at Health-ISAC Summit

LOS ANGELES--(BUSINESS WIRE)--Saviynt, a leading provider of cloud-native identity and governance platform solutions, today announced that it will sponsor the…

8 months ago